Used as a key chiral intermediate in the synthesis of pharmaceuticals, particularly in the development of protease inhibitors and antiviral agents. Its structure supports high enantioselectivity, making it valuable in asymmetric synthesis for drugs targeting hepatitis C and other viral diseases. The sulfonamide group enhances binding affinity and metabolic stability in final drug compounds. Also employed in medicinal chemistry research for optimizing pharmacokinetic properties of new drug candidates.